Sopherion Therapeutics Company
Sopherion has the US and Canadian rights to this liposomal nanotechnology that targets the tumor vasculature.
Technology:
Biologics
Industry:
PharmTech
Headquarters:
East Brunswick, New Jersey, United States
Founded Date:
2001
Estimated Revenue:
$10M to $50M
Register and Claim Ownership